Improving the Quality and Cost—Effectiveness of Prescribing
Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Avorn, Jerry [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1992 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: PharmacoEconomics - Berlin [u.a.] : Springer, 1992, 1(1992), Suppl 1 vom: Juni, Seite 45-48 |
|---|---|
| Übergeordnetes Werk: |
volume:1 ; year:1992 ; number:Suppl 1 ; month:06 ; pages:45-48 |
| Links: |
|---|
| DOI / URN: |
10.2165/00019053-199200011-00011 |
|---|
| Katalog-ID: |
SPR033317909 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR033317909 | ||
| 003 | DE-627 | ||
| 005 | 20230519200556.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s1992 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2165/00019053-199200011-00011 |2 doi | |
| 035 | |a (DE-627)SPR033317909 | ||
| 035 | |a (SPR)00019053-199200011-00011-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Avorn, Jerry |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Improving the Quality and Cost—Effectiveness of Prescribing |
| 264 | 1 | |c 1992 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. | ||
| 650 | 4 | |a Inappropriate Prescribe |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Readable Format |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Esca |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Drug Utilisation Review |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a State Medicaid Programme |7 (dpeaa)DE-He213 | |
| 773 | 0 | 8 | |i Enthalten in |t PharmacoEconomics |d Berlin [u.a.] : Springer, 1992 |g 1(1992), Suppl 1 vom: Juni, Seite 45-48 |w (DE-627)327645717 |w (DE-600)2043876-X |x 1179-2027 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:1992 |g number:Suppl 1 |g month:06 |g pages:45-48 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.2165/00019053-199200011-00011 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2190 | ||
| 936 | b | k | |a 44.40 |q ASE |
| 951 | |a AR | ||
| 952 | |d 1 |j 1992 |e Suppl 1 |c 06 |h 45-48 | ||
| author_variant |
j a ja |
|---|---|
| matchkey_str |
article:11792027:1992----::mrvnteultadotfetvns |
| hierarchy_sort_str |
1992 |
| bklnumber |
44.40 |
| publishDate |
1992 |
| allfields |
10.2165/00019053-199200011-00011 doi (DE-627)SPR033317909 (SPR)00019053-199200011-00011-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Avorn, Jerry verfasserin aut Improving the Quality and Cost—Effectiveness of Prescribing 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. Inappropriate Prescribe (dpeaa)DE-He213 Readable Format (dpeaa)DE-He213 Esca (dpeaa)DE-He213 Drug Utilisation Review (dpeaa)DE-He213 State Medicaid Programme (dpeaa)DE-He213 Enthalten in PharmacoEconomics Berlin [u.a.] : Springer, 1992 1(1992), Suppl 1 vom: Juni, Seite 45-48 (DE-627)327645717 (DE-600)2043876-X 1179-2027 nnns volume:1 year:1992 number:Suppl 1 month:06 pages:45-48 https://dx.doi.org/10.2165/00019053-199200011-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 1 1992 Suppl 1 06 45-48 |
| spelling |
10.2165/00019053-199200011-00011 doi (DE-627)SPR033317909 (SPR)00019053-199200011-00011-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Avorn, Jerry verfasserin aut Improving the Quality and Cost—Effectiveness of Prescribing 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. Inappropriate Prescribe (dpeaa)DE-He213 Readable Format (dpeaa)DE-He213 Esca (dpeaa)DE-He213 Drug Utilisation Review (dpeaa)DE-He213 State Medicaid Programme (dpeaa)DE-He213 Enthalten in PharmacoEconomics Berlin [u.a.] : Springer, 1992 1(1992), Suppl 1 vom: Juni, Seite 45-48 (DE-627)327645717 (DE-600)2043876-X 1179-2027 nnns volume:1 year:1992 number:Suppl 1 month:06 pages:45-48 https://dx.doi.org/10.2165/00019053-199200011-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 1 1992 Suppl 1 06 45-48 |
| allfields_unstemmed |
10.2165/00019053-199200011-00011 doi (DE-627)SPR033317909 (SPR)00019053-199200011-00011-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Avorn, Jerry verfasserin aut Improving the Quality and Cost—Effectiveness of Prescribing 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. Inappropriate Prescribe (dpeaa)DE-He213 Readable Format (dpeaa)DE-He213 Esca (dpeaa)DE-He213 Drug Utilisation Review (dpeaa)DE-He213 State Medicaid Programme (dpeaa)DE-He213 Enthalten in PharmacoEconomics Berlin [u.a.] : Springer, 1992 1(1992), Suppl 1 vom: Juni, Seite 45-48 (DE-627)327645717 (DE-600)2043876-X 1179-2027 nnns volume:1 year:1992 number:Suppl 1 month:06 pages:45-48 https://dx.doi.org/10.2165/00019053-199200011-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 1 1992 Suppl 1 06 45-48 |
| allfieldsGer |
10.2165/00019053-199200011-00011 doi (DE-627)SPR033317909 (SPR)00019053-199200011-00011-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Avorn, Jerry verfasserin aut Improving the Quality and Cost—Effectiveness of Prescribing 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. Inappropriate Prescribe (dpeaa)DE-He213 Readable Format (dpeaa)DE-He213 Esca (dpeaa)DE-He213 Drug Utilisation Review (dpeaa)DE-He213 State Medicaid Programme (dpeaa)DE-He213 Enthalten in PharmacoEconomics Berlin [u.a.] : Springer, 1992 1(1992), Suppl 1 vom: Juni, Seite 45-48 (DE-627)327645717 (DE-600)2043876-X 1179-2027 nnns volume:1 year:1992 number:Suppl 1 month:06 pages:45-48 https://dx.doi.org/10.2165/00019053-199200011-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 1 1992 Suppl 1 06 45-48 |
| allfieldsSound |
10.2165/00019053-199200011-00011 doi (DE-627)SPR033317909 (SPR)00019053-199200011-00011-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Avorn, Jerry verfasserin aut Improving the Quality and Cost—Effectiveness of Prescribing 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. Inappropriate Prescribe (dpeaa)DE-He213 Readable Format (dpeaa)DE-He213 Esca (dpeaa)DE-He213 Drug Utilisation Review (dpeaa)DE-He213 State Medicaid Programme (dpeaa)DE-He213 Enthalten in PharmacoEconomics Berlin [u.a.] : Springer, 1992 1(1992), Suppl 1 vom: Juni, Seite 45-48 (DE-627)327645717 (DE-600)2043876-X 1179-2027 nnns volume:1 year:1992 number:Suppl 1 month:06 pages:45-48 https://dx.doi.org/10.2165/00019053-199200011-00011 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 44.40 ASE AR 1 1992 Suppl 1 06 45-48 |
| language |
English |
| source |
Enthalten in PharmacoEconomics 1(1992), Suppl 1 vom: Juni, Seite 45-48 volume:1 year:1992 number:Suppl 1 month:06 pages:45-48 |
| sourceStr |
Enthalten in PharmacoEconomics 1(1992), Suppl 1 vom: Juni, Seite 45-48 volume:1 year:1992 number:Suppl 1 month:06 pages:45-48 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Inappropriate Prescribe Readable Format Esca Drug Utilisation Review State Medicaid Programme |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
PharmacoEconomics |
| authorswithroles_txt_mv |
Avorn, Jerry @@aut@@ |
| publishDateDaySort_date |
1992-06-01T00:00:00Z |
| hierarchy_top_id |
327645717 |
| dewey-sort |
3610 |
| id |
SPR033317909 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR033317909</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519200556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1992 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00019053-199200011-00011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR033317909</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00019053-199200011-00011-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Avorn, Jerry</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Improving the Quality and Cost—Effectiveness of Prescribing</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1992</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inappropriate Prescribe</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Readable Format</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Esca</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Utilisation Review</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">State Medicaid Programme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">PharmacoEconomics</subfield><subfield code="d">Berlin [u.a.] : Springer, 1992</subfield><subfield code="g">1(1992), Suppl 1 vom: Juni, Seite 45-48</subfield><subfield code="w">(DE-627)327645717</subfield><subfield code="w">(DE-600)2043876-X</subfield><subfield code="x">1179-2027</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1992</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:45-48</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00019053-199200011-00011</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1992</subfield><subfield code="e">Suppl 1</subfield><subfield code="c">06</subfield><subfield code="h">45-48</subfield></datafield></record></collection>
|
| author |
Avorn, Jerry |
| spellingShingle |
Avorn, Jerry ddc 610 bkl 44.40 misc Inappropriate Prescribe misc Readable Format misc Esca misc Drug Utilisation Review misc State Medicaid Programme Improving the Quality and Cost—Effectiveness of Prescribing |
| authorStr |
Avorn, Jerry |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)327645717 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1179-2027 |
| topic_title |
610 ASE 44.40 bkl Improving the Quality and Cost—Effectiveness of Prescribing Inappropriate Prescribe (dpeaa)DE-He213 Readable Format (dpeaa)DE-He213 Esca (dpeaa)DE-He213 Drug Utilisation Review (dpeaa)DE-He213 State Medicaid Programme (dpeaa)DE-He213 |
| topic |
ddc 610 bkl 44.40 misc Inappropriate Prescribe misc Readable Format misc Esca misc Drug Utilisation Review misc State Medicaid Programme |
| topic_unstemmed |
ddc 610 bkl 44.40 misc Inappropriate Prescribe misc Readable Format misc Esca misc Drug Utilisation Review misc State Medicaid Programme |
| topic_browse |
ddc 610 bkl 44.40 misc Inappropriate Prescribe misc Readable Format misc Esca misc Drug Utilisation Review misc State Medicaid Programme |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
PharmacoEconomics |
| hierarchy_parent_id |
327645717 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
PharmacoEconomics |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)327645717 (DE-600)2043876-X |
| title |
Improving the Quality and Cost—Effectiveness of Prescribing |
| ctrlnum |
(DE-627)SPR033317909 (SPR)00019053-199200011-00011-e |
| title_full |
Improving the Quality and Cost—Effectiveness of Prescribing |
| author_sort |
Avorn, Jerry |
| journal |
PharmacoEconomics |
| journalStr |
PharmacoEconomics |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
1992 |
| contenttype_str_mv |
txt |
| container_start_page |
45 |
| author_browse |
Avorn, Jerry |
| container_volume |
1 |
| class |
610 ASE 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Avorn, Jerry |
| doi_str_mv |
10.2165/00019053-199200011-00011 |
| dewey-full |
610 |
| title_sort |
improving the quality and cost—effectiveness of prescribing |
| title_auth |
Improving the Quality and Cost—Effectiveness of Prescribing |
| abstract |
Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. |
| abstractGer |
Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. |
| abstract_unstemmed |
Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_702 GBV_ILN_2190 |
| container_issue |
Suppl 1 |
| title_short |
Improving the Quality and Cost—Effectiveness of Prescribing |
| url |
https://dx.doi.org/10.2165/00019053-199200011-00011 |
| remote_bool |
true |
| ppnlink |
327645717 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.2165/00019053-199200011-00011 |
| up_date |
2024-07-03T17:55:20.518Z |
| _version_ |
1803581464792530944 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR033317909</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519200556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1992 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00019053-199200011-00011</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR033317909</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00019053-199200011-00011-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Avorn, Jerry</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Improving the Quality and Cost—Effectiveness of Prescribing</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1992</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use, In the approach known as ‘academic detailing’, the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one—on—one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit—cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inappropriate Prescribe</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Readable Format</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Esca</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Utilisation Review</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">State Medicaid Programme</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">PharmacoEconomics</subfield><subfield code="d">Berlin [u.a.] : Springer, 1992</subfield><subfield code="g">1(1992), Suppl 1 vom: Juni, Seite 45-48</subfield><subfield code="w">(DE-627)327645717</subfield><subfield code="w">(DE-600)2043876-X</subfield><subfield code="x">1179-2027</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:1992</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:45-48</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00019053-199200011-00011</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">1992</subfield><subfield code="e">Suppl 1</subfield><subfield code="c">06</subfield><subfield code="h">45-48</subfield></datafield></record></collection>
|
| score |
7.398615 |